Low serum total bilirubin concentrations are associated with increased prevalence of metabolic syndrome in Chinese

Journal of Diabetes

Volumn 3, Issue 3, 2011, Pages 217-224

  Wu, Yaohua ^a   Li, Mian ^a   Xu, Min ^a   Bi, Yufang ^a   Li, Xiaoying ^a,b   Chen, Yuhong ^a   Ning, Guang ^a,b   Wang, Weiqing ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b University of Shanghai   (China)

Author keywords

Insulin resistance; Metabolic syndrome; Total bilirubin

Indexed keywords

BILIRUBIN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CHINESE; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; HYPERINSULINEMIA; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SMOKING;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BILIRUBIN; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHINA; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERINSULINISM; INFLAMMATION; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; TRIGLYCERIDES; URBAN HEALTH;

EID: 80051819472     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2011.00138.x     Document Type: Article

References (23)

1. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987; 235: 1043-6.
2. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: A major physiologic cytoprotectant. Proc Natl Acad Sci USA. 2005; 99: 16093-8.
3. Basiglio CL, Arriaga SM, Pelusa F, Almara AM, Kapitulnik J, Mottino AD. Complement activation and disease: Protective effects of hyperbilirubinaemia. Clin Sci. 2009; 118: 99-113.
4. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 1994; 40: 18-23.
5. Chen YH, Chau LY, Chen JW, Lin SJ. Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients. Diabetes Care. 2008; 31: 1615-1520.
6. Diousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Effect of serum albumin and bilirubin on the risk of myocardial infarction (the Framingham Offspring Study). Am J Cardiol. 2003; 91: 485-8.
7. Erdogan D, Gullu H, Yildirim E et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 2006; 184: 431-7.
8. Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol. 2008; 28: 166-72.
9. Lin LY, Kuo HK, Hwang JJ et al. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis. 2009; 203: 563-8.
10. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005; 25: 1038-44.
11. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: Findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003; 52: 2346-52.
12. Kapitulnik J, Maines MD. Pleiotropic functions of biliverdin reductase: Cellular signaling and generation of cytoprotective and cytotoxic bilirubin. Trends Pharmacol Sci. 2009; 30: 129-37.
13. Hanley AJ, Wagenknecht LE, D'Agostino RB Jr, Zinman B, Haffner SM. Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes. 2003; 52: 2740-7.
14. Li XY, Xu M, Wang JG et al. Serum C-reactive protein (CRP) and microalbuminuria in relation to fasting and 2-h postload plasma glucose in a Chinese population. Clin Endocrinol. 2009; 70: 691-7.
15. Xu M, Li XY, Wang JG et al. Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population. Diabetologia. 2009; 52: 1511-9.
16. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003; 107: 363-9.
17. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998; 21: 2191-2.
18. Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000; 23: 57-63.
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-97.
20. Grundy SM, Cleeman JI, Daniels R et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation. 2005; 112: 2735-52.
21. Kalousova M, Novotny L, Zima T, Braun M, Vitek L. Decreased levels of advanced glycation end-products in patients with Gilbert syndrome. Cell Mol Biol. 2005; 51: 387-92.
22. Vitek L, Malikova I, Kvasnicka J, Benakova H, Novotny L. Relationship between serum bilirubin and markers of inflammation and oxidative stress. J Gastroenterol Hepatol. 2007; 22: A235 (Abstract).
23. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000; 102: 42-7.